ZOLADEX LA DEPOT INJECTION 10.8 mg/syringe

INJECTION

**4.2 Posology and method of administration** Caution should be taken while inserting ZOLADEX LA 10.8mg into the anterior abdominal wall due to the proximity of underlying inferior epigastric artery and its branches. Use extra care when administering ZOLADEX LA 10.8mg to patients with a low body mass index and/or who are receiving full anticoagulation medication (see Section 4.4 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). For correct administration of ZOLADEX LA 10.8mg, see instructions on instruction card (see Section 6.6 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). **Adult Men:** One 10.8mg depot of ZOLADEX LA 10.8mg injected subcutaneously into the anterior abdominal wall, every 3 months (see Section 5.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). **Adult Women:** One depot of ZOLADEX LA 10.8mg injected subcutaneously into the anterior abdominal wall, every 12 weeks. **Elderly:** No dosage adjustment is necessary in the elderly. **Renal Impairment:** No dosage adjustment is necessary for patients with renal impairment. **Hepatic Impairment:** No dosage adjustment is necessary for patients with hepatic impairment. **Children:** Not indicated for use in children.